<Blinded Review: TIME_ANON_0312>
**Composite Score:** 7.2 / 10.0 (Rigor: 2.3/3.5 | Claims: 1.9/2.5 | Biology: 1.6/2.0 | Reproducibility: 1.4/2.0)
**Bias Category:** None (Methodologically Sound)
**Verdict:** Minor Revision
**Study Modality:** Wet-Lab Primary Experimental
**Technology Maturity:** Mature/Classical
**Epistemic Stage:** Basic/Mechanistic Discovery

---

### 1. Executive Summary
This study investigates the functional role and endocrine/paracrine regulation of C-type natriuretic peptide (`CNP`, encoded by `NPPC`) and its guanylyl cyclase receptor `NPR2` in primary porcine ovarian granulosa cells (GCs) and cumulus–oocyte complexes (COCs). First, comparing healthy versus atretic porcine antral follicles (`3–6 mm`, validated by morphological criteria, `TUNEL` staining, and qRT-PCR of atresia markers `DKK3`, `GADD45A`, `HMOX1`, `CCDC80`, and `DAPK2`), the authors show that `NPR2` mRNA and protein are markedly downregulated in degenerated GCs and COCs, whereas `NPPC` mRNA is elevated (`n = 6`). Second, exogenous `CNP` (`200 nM`) significantly reduces `TUNEL`-positive apoptosis and atresia-marker expression in cultured porcine GCs (`n = 4`). Third, estradiol (`E2`, `100 nM`) upregulates both `NPPC` and `NPR2` transcripts in GCs and synergizes with `CNP` to suppress germinal vesicle breakdown (`GVBD`) and pro-maturation transcripts (`BMP15`, `MOS`) in cultured COCs (`n = 6`). Finally, epidermal growth factor (`EGF`, `20 ng/mL`) downregulates `NPPC` and `NPR2` mRNA while inducing the mRNA-destabilizing protein tristetraprolin (`ZFP36`/`TTP`) in a MEK-dependent manner (blocked by `PD0325901`), and `ZFP36` overexpression reduces `NPPC` mRNA levels (`n = 3–4`).

The physiological experiments in primary porcine follicles, GCs, and COCs are logically structured, include rigorous qRT-PCR quality control (`geNorm`-validated `Rps18` reference, `90–110%` efficiency standard curves, no-RT and no-template controls), and feature a balanced Discussion that explicitly acknowledges the limitations of monolayer GC culture. Several methodological and reporting issues should be addressed in revision:
1. **Misapplication of one-way ANOVA + Tukey's post-hoc test to two-group comparisons:** Several experiments (`Figure 1C,D,F,G`, `Figure 2B,C`, `Figure 5A`, `Figure 6B,D,E`) consist of only two experimental groups (e.g., `HGC` vs. `DGC`, `Control` vs. `CNP`, `Control` vs. `ZFP36-OE`), yet both Section 4.9 and the figure legends state that all data were analyzed by one-way ANOVA followed by Tukey's multiple-comparison test (`"Values with superscript letters a and b are significantly different across columns according to Tukey's test"`).
2. **Antibody catalog and species mismatch in Section 4.5 (Immunofluorescence):** For `NPR2` immunofluorescence, Section 4.5 lists primary antibody `A7906, Sigma-Aldrich` (`1:5000`) and secondary antibody `488 goat anti-mouse IgG (A-11008, Thermo Fisher)`. However, `Sigma A7906` is an HRP-conjugated goat anti-mouse IgG secondary antibody (whereas the rabbit polyclonal anti-NPR2 antibody `55113-1-AP, Proteintech` was used in Section 4.4), and `Thermo Fisher A-11008` is Alexa Fluor 488 **goat anti-rabbit IgG**, not goat anti-mouse IgG.
3. **Incomplete epistasis link in the `EGF` $\rightarrow$ `TTP` $\rightarrow$ `NPPC` axis:** While the authors show that `EGF` induces `TTP` (inhibited by `PD0325901`) and that `ZFP36` overexpression reduces `NPPC` mRNA, they do not test whether `PD0325901` or `ZFP36` knockdown rescues `NPPC` mRNA levels during `EGF` treatment in porcine GCs.

### 2. Methodological & Statistical Audit
- **Primary Tissue Classification and qRT-PCR Rigor:**
  - Morphological separation of healthy vs. atretic `3–6 mm` porcine follicles is orthogonally validated by five transcriptional markers of follicular atresia (`DKK3`, `GADD45A`, `HMOX1`, `CCDC80`, `DAPK2`; `Figure 1C`) and `TUNEL` staining (`Figure 1E`).
  - Section 4.3 (`line 107`) describes exemplary qRT-PCR standards: pooled cDNA serial-dilution standard curves requiring `90–110%` amplification efficiency and $R^2 > 0.99$, minus-RT and minus-template controls in every run, and normalization to `Rps18` selected via `geNorm`.
- **Statistical Testing Audit (`Section 4.9` and Figure Legends):**
  - One-way ANOVA with Tukey's HSD test is appropriate for the multi-group experiments (`Figure 3A,B,D,E` across E2 concentrations or `Control`/`CNP`/`E2`/`CNP+E2` combinations; `Figure 5C,E` across time points or `Control`/`EGF`/`EGF+PD0325901`).
  - For two-group comparisons (`Figure 1`, `Figure 2`, `Figure 4`, `Figure 5A`, `Figure 6`), an unpaired two-tailed Student's $t$-test (with Welch's correction if variances are unequal) should be stated and used.
  - Additionally, for proportion data (`GVBD` rates in `Figure 3D` and `TUNEL` percentages in `Figure 2B`), reporting the total number of scored oocytes/cells per biological replicate and verifying normality (`Shapiro-Wilk`) or arcsine/logit transformation before parametric ANOVA is recommended.
- **Reagent Catalog Discrepancy (`Section 4.5` vs. `Section 4.4`):**
  - In Section 4.4 (`line 112`), Western blotting uses rabbit polyclonal `anti-NPR2 (55113-1-AP, Proteintech)`. In Section 4.5 (`line 117`), immunofluorescence for `NPR2` cites `A7906, Sigma-Aldrich` (`1:5000`) and `488 goat anti-mouse IgG (A-11008, Thermo Fisher)`. Because `A-11008` is Alexa Fluor 488 goat anti-rabbit IgG and `55113-1-AP` is a rabbit primary antibody, `A7906` and `"goat anti-mouse"` appear to be clerical errors in Section 4.5 that should be corrected.

### 3. Biological / Experimental Grounding & Claim Proportionality
- **Claim 1:** *"Follicular atresia in pigs was accompanied by a marked decline in the CNP receptor NPR2. Correspondingly, exogenous CNP suppressed apoptosis in cultured porcine granulosa cells."* `[Well Supported]`
  - Directly supported by `NPR2` qRT-PCR, Western blot, and immunofluorescence in healthy vs. degenerated follicles/COCs (`n = 6`) and `TUNEL` + atresia-marker reductions upon `200 nM` CNP treatment (`n = 4`).
- **Claim 2:** *"Estradiol can significantly promote the expression level of NPPC in porcine ovarian granulosa cells and, by enhancing NPR2 levels, it can synergize with CNP to inhibit oocyte meiotic resumption in vitro."* `[Well Supported]`
  - Supported by dose-dependent `E2` induction of `NPPC`/`NPR2` in GCs and significantly reduced `GVBD` rates and `BMP15`/`MOS` expression in `CNP + E2`–treated COCs compared with `CNP` alone (`Figure 3C–E`, `n = 6`).
- **Claim 3:** *"Conversely, EGF signaling can significantly downregulate NPPC mRNA expression in porcine granulosa cells, an effect likely mediated by ERK-activated tristetraprolin (TTP)."* `[Moderately Supported]`
  - The authors appropriately qualify this claim with `"likely mediated"` (`Abstract`) and `"may downregulate"` (`Conclusions`). Showing that `PD0325901` or `ZFP36` siRNA reverses `EGF`-induced `NPPC` downregulation would elevate this from correlative/parallel evidence to direct causal proof in porcine cells.

### 4. Reproducibility & Data Completeness
- **Reagent & Protocol Transparency:** Culture media, hormone catalog numbers (`N8768`, `E1024`, `SRP3027`), porcine `ZFP36` accession (`NM_001168419.1`), and ethics approval (`AW80804202-1-1`) are clearly stated, with primer sequences in `Table S1`.
- **Corrections Needed:** Fix the antibody catalog/species description in Section 4.5 (`A7906` / `A-11008`) and include `Table S1` primer sequences in the accessible supplementary materials.
</Blinded Review: TIME_ANON_0312>
